Category Health & Wellness
‘Bad guy’ fibrocytes could help rebuild damaged tissue
Could a blood cell type responsible for scarring and diseases such as pulmonary fibrosis be repurposed to help engineer healthy tissue? A new study by…
Medical school grad follows mother’s footsteps in rural medicine
Mary Finta, who will graduate with an M.D. on May 10 from the UW–Madison School of Medicine and Public Health, has spent the past two years following her passion for rural medicine.
Fettiplace named a Passano Fellow; 2nd major award for hearing researcher
Fettiplace, a professor of neuroscience at the UW School of Medicine and Public Health, won the award for showing how cochlear hair cells sense the tiny mechanical vibrations that sound produces in the inner ear.
Clinical trial begins to test universal vaccine against canine cancer
Dogs started receiving a vaccine against cancer this week in a clinical trial at UW–Madison. If the vaccine works in dogs, it may not only provide a new strategy for addressing a critical canine health concern, it might also work in people.
Stressed parents rely on junk food for kids
“The higher their psychological distress, the less healthy food is available in the home and the more unhealthy the feeding practices are for their children,” says Myoungock Jang,
Nursing student upholds family tradition as fourth-generation Badger nurse
Following in the footsteps of her great-grandmother, grandmother and aunt, Emily Hanna is the fourth in her family to take part in UW–Madison’s nursing program. The program has seen some serious changes in that time.
H3N2 viruses mutate during vaccine production but new tech could fix it
UW-Madison researchers describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses.
Orthopedic injury therapy in rodents may soon be headed to the clinic
The research team is now working to obtain FDA approval for a first human clinical trial to treat devastating injuries in musculoskeletal tissues.
Microbiomes of diabetic foot ulcers are associated with clinical outcomes
New research suggests that the microbial communities associated with chronic wounds common in diabetic patients affect whether those wounds heal or lead to amputations.
Novel approach promises ready access to hard-to-study proteins
The new strategy promises a trove of biological insights and, importantly, may help identify therapeutically relevant proteins and provide new disease diagnostic techniques.
Antibiotic resistance across Wisconsin revealed by new maps
Researchers drew inspiration from easy-to-read weather maps and consulted with doctors to provide guidance at a glance of the likelihood a pathogen will respond to a particular drug in different parts of the state.
Blood-based screen for colon cancer shows promise
The scientists expect their findings will ultimately lead to a blood test for the cancer, adding a method to help increase screening rates while reducing overtreatment.
UW–Madison helps confront rural health crisis
Multiple UW–Madison sources are interviewed in "Medicine on Main Street," a new WPT documentary about the health care challenges rural areas of Wisconsin are facing and what is being done to meet them. The program debuts Monday, April 8, at 9:30 p.m.
School of Veterinary Medicine assists Wisconsin animal shelters with canine brucellosis response
Two dogs recently transported from overseas to animal shelters and rescue groups in Wisconsin have tested positive for canine brucellosis. The UW–Madison Shelter Medicine Program is advising the shelters on quarantine procedures.
After winning online vote, researchers to assemble German shepherd genome
This genome will allow the group to expand its research into diseases that affect German shepherds. It will also contribute to further understanding of structural variation between the genomes of different dog breeds.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
UW team finds key to common cancer pathway in discovery that could unlock new therapies
A team led by UW cancer researchers discovered an unexpected regulator of the critical protein p53, opening the door to the development of drugs that could target it.
Doctor’s brainstorm being realized at UW–Madison spinoff
Atrility hopes to market a device that would help in pediatric heart surgery. The design was begun by students in UW–Madison’s department of biomedical engineering.
THOR wrangles complex microbiomes into a model for improving them
A growing understanding of microbial communities and their influence on human health or crop productivity has led to the dream of changing these communities to produce benefits. New research addresses this head-on.
MR Guidance: Next frontier in hemorrhagic stroke
A UW–Madison startup called InseRT MRI has the goal of guiding drug placements in the brain with MRI, under a license to a patent held by WARF.